ÂÜÀòÂÒÂ×

Donald R. Dye is an experienced investor and advisor with a diverse portfolio in the biotechnology and healthcare sectors. Current roles include Founding Investor at Breakwater Biotech, Inc., and Investor at CoreWeave, an AI hyperscaler. In addition, Donald serves as an investor and advisor for Koning Corporation, focused on non-compression breast imaging technology, and co-founded Tarus Therapeutics and LeviSense Medical, both aimed at innovative healthcare solutions. Other notable positions include membership on the Board of Trustees and Treasurer for amfAR, early investor roles in Akston Biosciences and Tvardi Therapeutics, and involvement with Etiometry Inc. and Prospective Research, Inc. Academically, Donald holds an MBA in Finance from Northwestern University's Kellogg School of Management and possesses language certificates in Mandarin and German, complemented by a Bachelor's degree in Economics with minors in Biochemistry and Chinese.